{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:34:34Z","timestamp":1793406874359,"version":"4.5.0"},"reference-count":171,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The landscape of chronic liver disease in Egypt has drastically changed over the past few decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to alarming levels. Despite the magnitude of the problem, no regional guidelines have been developed to tackle this disease. This document provides the clinical practice guidelines of the key Egyptian opinion leaders on MAFLD screening, diagnosis, and management, and covers various aspects in the management of MAFLD. The document considers our local situations and the burden of clinical management for the healthcare sector and is proposed for daily clinical practical use. Particular reference to special groups was done whenever necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_357_21","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T04:14:52Z","timestamp":1643084092000},"page":"3-20","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["The Egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease"],"prefix":"10.4103","volume":"28","author":[{"given":"Yasser","family":"Fouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Esmat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Elwakil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serag","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Yosry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imam","family":"Waked","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maissa","family":"El-Razky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wahid","family":"Doss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdy","family":"El-Serafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebraheem","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Anees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Sakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"AbdelAty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amgad","family":"Al-zahaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdy","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysaa","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Albendary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Khalek","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Abdel-baky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"El sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Shiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebada","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamardan","family":"Bazeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Mehrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Abdelaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa A.","family":"Tawab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa","family":"Nafady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20240829","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/bmj.323.7308.334","article-title":"A new system for grading recommendations in evidence based guidelines","volume":"323","author":"Harbour","year":"2001","journal-title":"BMJ"},{"key":"R2-2-20240829","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1017\/S1368980011003673","article-title":"Dietary trends in the Middle East and North Africa: An ecological study (1961 to 2007)","volume":"15","author":"Golzarand","year":"2012","journal-title":"Public Health Nutr"},{"key":"R3-2-20240829","first-page":"98","article-title":"Nutritional status and anthropometric measurements among women in Egypt, National Survey 2001\u20132002","volume":"11","author":"Mahmood","year":"2004","journal-title":"Arab J Food Nutr"},{"key":"R5-2-20240829","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S2468-1253(18)30268-1","article-title":"National Committee for the Control of Viral Hepatitis. One step closer to elimination of hepatitis C in Egypt","volume":"3","author":"Esmat","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R6-2-20240829","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1079\/PHN2001286","article-title":"The nutrition transition in Egypt: Obesity, undernutrition and the food consumption context","volume":"5","author":"Galal","year":"2002","journal-title":"Public Health Nutr"},{"key":"R7-2-20240829","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrcardio.2017.138","article-title":"Cardiovascular disease in the Eastern Mediterranean region: Epidemiology and risk factor burden","volume":"15","author":"Turk-Adawi","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R8-2-20240829","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(19)30179-2","article-title":"Metabolic health in the Middle East and north Africa","volume":"7","author":"Azizi","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R9-2-20240829","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"R10-2-20240829","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1016\/S2214-109X(18)30357-7","article-title":"Worldwide trends in insufficient physical activity from 2001 to 2016: A pooled analysis of 358 population-based surveys with 1.9 million participants","volume":"6","author":"Guthold","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R11-2-20240829","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"R12-2-20240829","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41575-019-0212-0","article-title":"Genetic contributions to NAFLD: Leveraging shared genetics to uncover systems biology","volume":"17","author":"Eslam","year":"2020","journal-title":"Nat Rev Gastro Hepat"},{"key":"R13-2-20240829","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol"},{"key":"R15-2-20240829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajg.2014.05.002","article-title":"Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: A hospital-based study in Alexandria, Egypt","volume":"15","author":"Alkassabany","year":"2014","journal-title":"Arab J Gastroenterol"},{"key":"R17-2-20240829","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jhep.2021.01.022","article-title":"Capturing patient experience: A qualitative study of change from NAFLD to MAFLD real-time feedback","volume":"74","author":"Abdel Alem S","year":"2021","journal-title":"J Hepatol"},{"key":"R18-2-20240829","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jhep.2020.12.035","article-title":"Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists","volume":"74","author":"Fouad","year":"2021","journal-title":"J Hepatol"},{"key":"R19-2-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-018-1103-x","article-title":"Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease","volume":"16","author":"Alexander","year":"2018","journal-title":"BMC Med"},{"key":"R20-2-20240829","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.3399\/bjgp18X699377","article-title":"GPs' experiences and perceptions of early detection of liver disease: A qualitative study in primary care","volume":"68","author":"Standing","year":"2018","journal-title":"Br J Gen Pract"},{"key":"R21-2-20240829","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep4.1018","article-title":"Nonalcoholic fatty liver disease-related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma","volume":"1","author":"Bertot","year":"2017","journal-title":"Hepatol Commun"},{"key":"R22-2-20240829","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2468-1253(20)30213-2","article-title":"Nomenclature and definition of metabolic-associated fatty liver disease: A consensus from the Middle East and north Africa","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R23-2-20240829","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/j.gastro.2019.05.064","article-title":"Toward more accurate nomenclature for fatty liver diseases","volume":"157","author":"Eslam","year":"2019","journal-title":"Gastroenterology"},{"key":"R24-2-20240829","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R25-2-20240829","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: An international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R26-2-20240829","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/liv.14739","article-title":"The NAFLD-MAFLD debate: Eminence vs evidence","volume":"41","author":"Fouad","year":"2021","journal-title":"Liver Int"},{"key":"R27-2-20240829","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"R28-2-20240829","first-page":"2138","article-title":"Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: A nationwide cohort study","volume":"22","author":"Lee","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-2-20240829","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/hepr.13685","article-title":"MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach","volume":"51","author":"Tsutsumi","year":"2021","journal-title":"Hepatol Res"},{"key":"R30-2-20240829","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2468-1253(20)30340-X","article-title":"The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease","volume":"6","author":"Mendez-Sanchez","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R31-2-20240829","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"R32-2-20240829","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/CM9.0000000000000981","article-title":"From NAFLD to MAFLD: A \u201credefining\u201d moment for fatty liver disease","volume":"133","author":"Zheng","year":"2020","journal-title":"Chin Med J (Engl"},{"key":"R33-2-20240829","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R34-2-20240829","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jhep.2013.08.011","article-title":"Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team","volume":"60","author":"Dyson","year":"2014","journal-title":"J Hepatol"},{"key":"R35-2-20240829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/cld.890","article-title":"The rising threat of hepatocellular carcinoma in the Middle East and North Africa region: Results from global burden of disease study 2017","volume":"14","author":"Sharafi","year":"2019","journal-title":"Clin Liver Dis (Hoboken"},{"key":"R37-2-20240829","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"R38-2-20240829","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: Risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"Stine","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R40-2-20240829","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cld.885","article-title":"The burden and clinical care pathways of nonalcoholic steatohepatitis in the Middle east","volume":"14","author":"Hasan","year":"2019","journal-title":"Clin Liver Dis (Hoboken"},{"key":"R41-2-20240829","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jceh.2019.07.008","article-title":"Extra-hepatic manifestations of nonalcoholic fatty liver disease: A review","volume":"10","author":"Tariq","year":"2020","journal-title":"J Clin Exp Hepatol"},{"key":"R42-2-20240829","doi-asserted-by":"crossref","first-page":"e1001680","DOI":"10.1371\/journal.pmed.1001680","article-title":"Association of non-alcoholic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"Plos Med"},{"key":"R43-2-20240829","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.2215\/CJN.05050610","article-title":"Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis","volume":"5","author":"Targher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R44-2-20240829","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","article-title":"Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease","volume":"49","author":"Ong","year":"2008","journal-title":"J Hepatol"},{"key":"R45-2-20240829","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"R46-2-20240829","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: A multi-national cohort study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"R47-2-20240829","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"R48-2-20240829","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH-current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R49-2-20240829","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"R50-2-20240829","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"key":"R51-2-20240829","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"R52-2-20240829","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","article-title":"Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter","volume":"67","author":"Wong","year":"2017","journal-title":"J Hepatol"},{"key":"R53-2-20240829","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cgh.2019.11.060","article-title":"Prospective, same-day, direct comparison of controlled attenuation parameter with the M vs the XL probe in patients with nonalcoholic fatty liver disease, using magnetic resonance imaging\u2013proton density fat fraction as the standard","volume":"18","author":"Caussy","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R54-2-20240829","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"R55-2-20240829","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: A simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC gastroenterology"},{"key":"R56-2-20240829","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.jhep.2020.06.003","article-title":"Blood biomarkers for the diagnosis of hepatic steatosis in metabolic dysfunction-associated fatty liver disease","volume":"73","author":"Xu","year":"2020","journal-title":"J Hepatol"},{"key":"R57-2-20240829","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"R58-2-20240829","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R59-2-20240829","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"R60-2-20240829","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14744\/hf.2020.0006","article-title":"The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases","volume":"1","author":"Kaya","year":"2020","journal-title":"Hepatol Forum"},{"key":"R61-2-20240829","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00592-019-01467-7","article-title":"Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: A study in biopsy-proven non-alcoholic fatty liver disease","volume":"57","author":"Alkayyali","year":"2020","journal-title":"Acta Diabetol"},{"key":"R62-2-20240829","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.30163","article-title":"ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis","volume":"69","author":"Daniels","year":"2019","journal-title":"Hepatology"},{"key":"R63-2-20240829","doi-asserted-by":"crossref","first-page":"984","DOI":"10.14309\/ajg.0000000000001059","article-title":"A sequential algorithm combining ADAPT and liver stiffness can stage metabolic-associated fatty liver disease in hospital-based and primary care patients","volume":"116","author":"Eslam","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R64-2-20240829","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/hep.31142","article-title":"Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study","volume":"72","author":"Lee","year":"2020","journal-title":"Hepatology"},{"key":"R65-2-20240829","doi-asserted-by":"crossref","first-page":"795","DOI":"10.5604\/01.3001.0012.3138","article-title":"Chronic hepatitis C patients with obesity: Do we need two operators for accurate evaluation of liver stiffness?","volume":"17","author":"Shiha","year":"2018","journal-title":"Ann Hepatol"},{"key":"R66-2-20240829","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"key":"R67-2-20240829","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"R68-2-20240829","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/j.cgh.2019.03.006","article-title":"Optimizing use of nonalcoholic fatty liver disease fibrosis score, fibrosis-4 score, and liver stiffness measurement to identify patients with advanced fibrosis","volume":"17","author":"Chan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R69-2-20240829","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJM200106283442614","article-title":"Liver biopsy","volume":"344","author":"Spinzi","year":"2001","journal-title":"N Engl J Med"},{"key":"R70-2-20240829","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R71-2-20240829","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"R72-2-20240829","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"key":"R73-2-20240829","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R74-2-20240829","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J Hepatol"},{"key":"R75-2-20240829","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","article-title":"The epidemiology of cirrhosis in the United States: A population-based study","volume":"49","author":"Scaglione","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"R76-2-20240829","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"R77-2-20240829","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2016.04.023","article-title":"Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease","volume":"65","author":"Boursier","year":"2016","journal-title":"J Hepatol"},{"key":"R78-2-20240829","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJMra1504367","article-title":"Treatment of patients with cirrhosis","volume":"375","author":"Ge","year":"2016","journal-title":"New Engl J Med"},{"key":"R79-2-20240829","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","article-title":"Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease","volume":"48","author":"Chalasani","year":"2008","journal-title":"J Hepatol"},{"key":"R80-2-20240829","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.dld.2007.08.011","article-title":"New abdominal collaterals at ultrasound: A clue of progression of portal hypertension","volume":"40","author":"Berzigotti","year":"2008","journal-title":"Dig Liver Dis"},{"key":"R81-2-20240829","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/hep.29363","article-title":"Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease","volume":"66","author":"Augustin","year":"2017","journal-title":"Hepatology"},{"key":"R82-2-20240829","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cgh.2019.04.062","article-title":"Performance of Baveno VI and expanded Baveno VI criteria for excluding high-risk varices in patients with chronic liver diseases: A systematic review and meta-analysis","volume":"17","author":"Stafylidou","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R83-2-20240829","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jhep.2020.06.042","article-title":"Validation of Baveno VI and expanded Baveno VI criteria to identify high-risk varices in patients with MAFLD-related compensated cirrhosis","volume":"73","author":"Zheng","year":"2020","journal-title":"J Hepatol"},{"key":"R84-2-20240829","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology (Baltimore, Md"},{"key":"R85-2-20240829","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"R86-2-20240829","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1665-2681(19)31343-2","article-title":"Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables","volume":"12","author":"Eslam","year":"2013","journal-title":"Ann Hepatol"},{"key":"R87-2-20240829","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: Expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"R88-2-20240829","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: New trends","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"},{"key":"R89-2-20240829","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: A meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"R90-2-20240829","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/hepr.12365","article-title":"Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography","volume":"45","author":"Mikami","year":"2015","journal-title":"Hepatol Res"},{"key":"R91-2-20240829","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2019.12.001","article-title":"Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound","volume":"72","author":"Park","year":"2020","journal-title":"J Hepatol"},{"key":"R92-2-20240829","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/hep.1840160122","article-title":"Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival","volume":"16","author":"Barbara","year":"1992","journal-title":"Hepatology"},{"key":"R93-2-20240829","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2010.03.010","article-title":"Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival","volume":"53","author":"Santi","year":"2010","journal-title":"J Hepatol"},{"key":"R94-2-20240829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R95-2-20240829","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"New Engl J Med"},{"key":"R96-2-20240829","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/MEG.0000000000000776","article-title":"Coffee consumption and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"29","author":"Wijarnpreecha","year":"2017","journal-title":"Eur J Gastroen Hepatol"},{"key":"R97-2-20240829","doi-asserted-by":"crossref","first-page":"e111808","DOI":"10.1371\/journal.pone.0111808","article-title":"Weight loss in nonalcoholic fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits","volume":"9","author":"Dudekula","year":"2014","journal-title":"Plos One"},{"key":"R98-2-20240829","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jhep.2018.07.013","article-title":"An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers","volume":"69","author":"Mazzotti","year":"2018","journal-title":"J Hepatol"},{"key":"R99-2-20240829","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.cgh.2019.11.022","article-title":"Alcohol use is associated with hepatic steatosis among persons with presumed non-alcoholic fatty liver disease","volume":"18","author":"Long","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R100-2-20240829","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/hep.30170","article-title":"Nonheavy drinking and worsening of noninvasive fibrosis markers in nonalcoholic fatty liver disease: A cohort study","volume":"69","author":"Chang","year":"2019","journal-title":"Hepatology"},{"key":"R101-2-20240829","doi-asserted-by":"crossref","first-page":"154439","DOI":"10.1016\/j.metabol.2020.154439","article-title":"Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus","volume":"115","author":"Blomdahl","year":"2021","journal-title":"Metabolism"},{"key":"R102-2-20240829","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/hep.29631","article-title":"Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population","volume":"67","author":"Aberg","year":"2018","journal-title":"Hepatology"},{"key":"R103-2-20240829","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1002\/hep.23527","article-title":"The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis","volume":"51","author":"Ascha","year":"2010","journal-title":"Hepatology"},{"key":"R104-2-20240829","doi-asserted-by":"crossref","first-page":"e14918","DOI":"10.1097\/MD.0000000000014918","article-title":"A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease","volume":"98","author":"Abdelbasset","year":"2019","journal-title":"Medicine"},{"key":"R105-2-20240829","doi-asserted-by":"crossref","first-page":"43029","DOI":"10.1038\/srep43029","article-title":"High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease","volume":"7","author":"Oh","year":"2017","journal-title":"Sci Rep-Uk"},{"key":"R106-2-20240829","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2015.08.028","article-title":"Hepatocellular carcinoma and lifestyles","volume":"64","author":"Saran","year":"2016","journal-title":"J Hepatol"},{"key":"R107-2-20240829","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1249\/MSS.0b013e318213fefb","article-title":"Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise","volume":"43","author":"Garber","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"R108-2-20240829","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/jamainternmed.2016.3202","article-title":"Effects of moderate and vigorous exercise on nonalcoholic fatty liver disease: A randomized clinical trial","volume":"176","author":"Zhang","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R109-2-20240829","doi-asserted-by":"crossref","first-page":"e19471","DOI":"10.1097\/MD.0000000000019471","article-title":"Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial","volume":"99","author":"Abdelbasset","year":"2020","journal-title":"Medicine"},{"key":"R110-2-20240829","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00535-015-1114-8","article-title":"Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery","volume":"51","author":"Seki","year":"2016","journal-title":"J Gastroenterol"},{"key":"R111-2-20240829","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.soard.2014.06.015","article-title":"Liver disease in the morbidly obese: A review of 1000 consecutive patients undergoing weight loss surgery","volume":"11","author":"Subichin","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"R112-2-20240829","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00464-020-07725-y","article-title":"Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: A prospective study","volume":"35","author":"Salman","year":"2020","journal-title":"Surg Endosc"},{"key":"R113-2-20240829","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/jgh.15029","article-title":"Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels","volume":"35","author":"Salman","year":"2020","journal-title":"J Gastroen Hepatol"},{"key":"R114-2-20240829","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.metabol.2015.09.004","article-title":"The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome","volume":"65","author":"Aguilar-Olivos","year":"2016","journal-title":"Metabolism"},{"key":"R115-2-20240829","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.suc.2016.03.008","article-title":"The Effects of Metabolic Surgery on fatty liver disease and nonalcoholic steatohepatitis","volume":"96","author":"Clanton","year":"2016","journal-title":"Surg Clin North Am"},{"key":"R117-2-20240829","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"R118-2-20240829","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cgh.2011.07.007","article-title":"Increased perioperative mortality following bariatric surgery among patients with cirrhosis","volume":"9","author":"Mosko","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R119-2-20240829","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00464-020-07498-4","article-title":"Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis","volume":"35","author":"Salman","year":"2020","journal-title":"Surg Endosc"},{"key":"R120-2-20240829","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/liv.14441","article-title":"Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives","volume":"40","author":"Salomone","year":"2020","journal-title":"Liver Int"},{"key":"R121-2-20240829","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R123-2-20240829","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"New Engl J Med"},{"key":"R124-2-20240829","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: A randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"key":"R125-2-20240829","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"New Engl J Med"},{"key":"R126-2-20240829","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"R127-2-20240829","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: A randomized controlled trial","volume":"42","author":"Bril","year":"2019","journal-title":"Diabetes Care"},{"key":"R128-2-20240829","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s13340-018-0360-4","article-title":"Pioglitazone use and risk of bladder cancer: A systematic literature review and meta-analysis of observational studies","volume":"10","author":"Mehtala","year":"2019","journal-title":"Diabetol Int"},{"key":"R129-2-20240829","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/1753-0407.12833","article-title":"Effect of pioglitazone on bone mineral density in patients with nonalcoholic steatohepatitis: A 36-month clinical trial","volume":"11","author":"Portillo-Sanchez","year":"2019","journal-title":"J Diabetes"},{"key":"R130-2-20240829","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"R131-2-20240829","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"key":"R132-2-20240829","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"R133-2-20240829","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed Rep"},{"key":"R134-2-20240829","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cgh.2020.04.083","article-title":"Type 2 diabetes and metformin use associate with outcomes of patients with non-alcoholic steatohepatitis-related, Child-Pugh A cirrhosis","volume":"19","author":"Vilar-Gomez","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R135-2-20240829","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.aohep.2019.11.008","article-title":"Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes","volume":"19","author":"Zhou","year":"2020","journal-title":"Ann Hepatol"},{"key":"R136-2-20240829","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/j.1572-0241.2003.08699.x","article-title":"Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis","volume":"98","author":"Harrison","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R137-2-20240829","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/apt.12352","article-title":"Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis","volume":"38","author":"Hoofnagle","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R138-2-20240829","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.nut.2014.11.018","article-title":"Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"31","author":"Sato","year":"2015","journal-title":"Nutrition"},{"key":"R139-2-20240829","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/1319-3767.132983","article-title":"Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis","volume":"20","author":"Sarkhy","year":"2014","journal-title":"Saudi J Gastroenterol"},{"key":"R140-2-20240829","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/postgradmedj-2018-136364","article-title":"Effect of vitamin E in non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Amanullah","year":"2019","journal-title":"Postgrad Med J"},{"key":"R141-2-20240829","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.30368","article-title":"Vitamin E improves transplant-free survival and hepatic decompensation among patients with nonalcoholic steatohepatitis and advanced fibrosis","volume":"71","author":"Vilar-Gomez","year":"2020","journal-title":"Hepatology"},{"key":"R142-2-20240829","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.2011.1437","article-title":"Vitamin E and the risk of prostate cancer: The selenium and vitamin E cancer prevention trial (SELECT)","volume":"306","author":"Klein","year":"2011","journal-title":"JAMA"},{"key":"R144-2-20240829","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: A post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet"},{"key":"R145-2-20240829","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(19)32963-0","article-title":"Obeticholic acid: Towards first approval for NASH","volume":"394","author":"Eslam","year":"2019","journal-title":"Lancet"},{"key":"R146-2-20240829","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"R147-2-20240829","doi-asserted-by":"crossref","first-page":"486","DOI":"10.5009\/gnl19173","article-title":"Simple noninvasive scores are clinically useful to exclude, not predict, advanced fibrosis: A study in Turkish patients with biopsy-proven nonalcoholic fatty liver disease","volume":"14","author":"Kaya","year":"2019","journal-title":"Gut Liver"},{"key":"R148-2-20240829","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/MEG.0000000000001573","article-title":"The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: A biopsy-proven nonalcoholic fatty liver disease study","volume":"32","author":"Jafarov","year":"2020","journal-title":"Eur J Gastroen Hepat"},{"key":"R149-2-20240829","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.cgh.2019.02.024","article-title":"Reduced patient-reported outcome scores associate with level of fibrosis in patients with nonalcoholic steatohepatitis","volume":"17","author":"Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R150-2-20240829","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.cgh.2018.12.016","article-title":"Health-related quality of life in nonalcoholic fatty liver disease associates with hepatic inflammation","volume":"17","author":"Huber","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R151-2-20240829","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/hep.30125","article-title":"Patient-reported outcomes and the economic effects of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: The value proposition","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"R152-2-20240829","doi-asserted-by":"crossref","first-page":"S570","DOI":"10.1016\/S0168-8278(18)31397-7","article-title":"Measuring what matters to patients: The development of the NASH-CHECK, a new patient-reported outcome instrument for nonalcoholic steatohepatitis","volume":"68","author":"Doward","year":"2018","journal-title":"J Hepatol"},{"key":"R153-2-20240829","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/liv.13391","article-title":"A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD","volume":"37","author":"Younossi","year":"2017","journal-title":"Liver Int"},{"key":"R154-2-20240829","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","article-title":"Non-alcoholic fatty liver disease in non-obese individuals: The impact of metabolic health","volume":"5","author":"Eslam","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R155-2-20240829","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R156-2-20240829","doi-asserted-by":"crossref","first-page":"S909","DOI":"10.1016\/S0016-5085(14)63307-2","article-title":"Characteristics and long-term prognosis of lean patients with nonalcoholic fatty liver disease","volume":"146","author":"Dela Cruz","year":"2014","journal-title":"Gastroenterology"},{"key":"R157-2-20240829","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: A distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"R158-2-20240829","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cld.930","article-title":"NAFLD in Lean Asians","volume":"16","author":"Eslam","year":"2021","journal-title":"Clin Liver Dis (Hoboken"},{"key":"R159-2-20240829","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"},{"key":"R161-2-20240829","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3748\/wjg.v24.i11.1269","article-title":"Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals","volume":"24","author":"Noureddin","year":"2018","journal-title":"World J Gastroenterol"},{"key":"R162-2-20240829","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhepr.2019.02.002","article-title":"Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load","volume":"1","author":"Peleg","year":"2019","journal-title":"JHEP Rep"},{"key":"R163-2-20240829","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/apt.16346","article-title":"MAFLD considerations as a part of the global hepatitis C elimination effort: An international perspective","volume":"53","author":"Fouad","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"R164-2-20240829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1024\/0300-9831\/a000442","article-title":"Ramadan fasting improves liver function and total cholesterol in patients with nonalcoholic fatty liver disease","volume":"90","author":"Ebrahimi","year":"2020","journal-title":"Int J Vitam Nutr Res"},{"key":"R165-2-20240829","first-page":"94","article-title":"The impact of Ramadan fasting on fatty liver disease severity: A retrospective case control study from Israel","volume":"23","author":"Mari","year":"2021","journal-title":"Isr Med Assoc J"},{"key":"R166-2-20240829","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMra1905136","article-title":"Effects of intermittent fasting on health, aging, and disease","volume":"381","author":"de Cabo","year":"2019","journal-title":"New Engl J Med"},{"key":"R167-2-20240829","first-page":"2355","article-title":"Impact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma","volume":"19","author":"Hashida","year":"2020","journal-title":"Oncol Lett"},{"key":"R168-2-20240829","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"},{"key":"R169-2-20240829","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J Hepatol"},{"key":"R170-2-20240829","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/hepr.12674","article-title":"Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma","volume":"46","author":"Harimoto","year":"2016","journal-title":"Hepatol Res"},{"key":"R171-2-20240829","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3892\/ol.2017.6287","article-title":"Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy","volume":"14","author":"Nishikawa","year":"2017","journal-title":"Oncol Lett"},{"key":"R172-2-20240829","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4143\/crt.2017.232","article-title":"Sarcopenia predicts prognosis in patients with newly diagnosed hepatocellular carcinoma, independent of tumor stage and liver function","volume":"50","author":"Ha","year":"2018","journal-title":"Cancer Res Treat"},{"key":"R173-2-20240829","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/nu9101054","article-title":"Sarcopenia impairs prognosis of patients with hepatocellular carcinoma: The role of liver functional reserve and tumor-related factors in loss of skeletal muscle volume","volume":"9","author":"Imai","year":"2017","journal-title":"Nutrients"},{"key":"R174-2-20240829","doi-asserted-by":"crossref","first-page":"e0198812","DOI":"10.1371\/journal.pone.0198812","article-title":"Impact of pre-sarcopenia in sorafenib treatment for advanced hepatocellular carcinoma","volume":"13","author":"Takada","year":"2018","journal-title":"PLoS One"},{"key":"R175-2-20240829","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12876-019-1152-4","article-title":"Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: A retrospective study","volume":"19","author":"Mardian","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"R176-2-20240829","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Liver Transpl"},{"key":"R177-2-20240829","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2013.09.023","article-title":"Outcomes of liver transplantation for nonalcoholic steatohepatitis: A systematic review and meta-analysis","volume":"12","author":"Wang","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R178-2-20240829","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.TP.0000100685.70064.90","article-title":"Is there disparity between risk and incidence of cardiovascular disease after liver transplant?","volume":"77","author":"Neal","year":"2004","journal-title":"Transplantation"},{"key":"R179-2-20240829","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2010.11.004","article-title":"Liver transplantation using fatty livers: Always feasible?","volume":"54","author":"McCormack","year":"2011","journal-title":"J Hepatol"},{"key":"R180-2-20240829","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/lt.25613","article-title":"The impact of coronary artery disease and statins on survival after liver transplantation","volume":"25","author":"Patel","year":"2019","journal-title":"Liver Transpl"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_357_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:07:43Z","timestamp":1787166463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_357_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_357_21","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}